Endocrine and metabolic adaptations to pregnancy; Impact of obesity

Hormone Molecular Biology and Clinical Investigation

Volumn 24, Issue 1, 2015, Pages 65-72

  Mouzon, Sylvie Hauguel De ^a   Lassance, Luciana ^a  

^a METROHEALTH MEDICAL CENTER   (United States)

Author keywords

endocrine hormones; insulin resistance; obesity; pregnancy

Indexed keywords

INSULIN; STEROID HORMONE;

ADIPOSE TISSUE; ARTICLE; BODY COMPOSITION; DISORDERS OF MITOCHONDRIAL FUNCTIONS; ENDOCRINE FUNCTION; FEMALE; HOMEOSTASIS; HUMAN; INFLAMMATION; INSULIN RESISTANCE; MATERNAL OBESITY; METABOLIC DISORDER; METABOLISM; PLACENTA; PREGNANCY; PREGNANCY COMPLICATION; PRIORITY JOURNAL; REGULATORY MECHANISM; STEROIDOGENESIS; TISSUE METABOLISM; ADAPTATION; COMPLICATION; ENDOCRINE SYSTEM; FETUS DEVELOPMENT; OBESITY; PHYSIOLOGY;

ADAPTATION, PHYSIOLOGICAL; ADIPOSITY; BODY COMPOSITION; ENDOCRINE SYSTEM; FEMALE; FETAL DEVELOPMENT; HUMANS; INSULIN RESISTANCE; OBESITY; PLACENTA; PREGNANCY;

EID: 84958819042     PISSN: 18681883     EISSN: 18681891     Source Type: Journal    
DOI: 10.1515/hmbci-2015-0042     Document Type: Article

References (75)

1. Hytten FE. Water storage in pregnancy. Midwife Health Visit 1967;3:60-2.
2. Larciprete G, Valensise H, Vasapollo B, Altomare F, Sorge R, Casalino B, De Lorenzo A, Arduini D. Body composition during normal pregnancy: reference ranges. Acta Diabetol 2003;40:S225-32.
3. King JC, Butte NF, Bronstein MN, Kopp LE, Lindquist SA. Energy metabolism during pregnancy: influence of maternal energy status. Am J Clin Nutr 1994;59:439S-45S.
4. Poppitt SD, Prentice AM, Goldberg GR, Whitehead RG. Energysparing strategies to protect human fetal growth. Am J Obstet Gynecol 1994;171:118-25.
5. Resi V, Basu S, Haghiac M, Presley L, Minium J, Kaufman B, Bernard S, Catalano P, Hauguel-de Mouzon S. Molecular inflammation and adipose tissue matrix remodeling precede physiological adaptations to pregnancy. Am J Physiol Endocrinol Metab 2012;303:E832-40.
6. Herrera E, Amusquivar E. Lipid metabolism in the fetus and the newborn. Diabetes Metab Res Rev 2000;16:202-10.
7. Meyer BJ, Stewart FM, Brown EA, Cooney J, Nilsson S, Olivecrona G, Ramsay JE, Griffin BA, Caslake MJ, Freeman DJ. Maternal obesity is associated with the formation of small dense LDL and hypoadiponectinemia in the third trimester. J Clin Endocrinol Metab 2013;98:643-52.
8. Potter JM, Nestel PJ. Hyperlipidemia of pregnancy in normal and complicated pregnancies. Am J Obstet Gynecol 1979;133:165-70.
9. Herrera E. Metabolic adaptations in pregnancy and their implications for the availability of substrates to the fetus. Eur J Clin Nutr 2000;54(Suppl 1):S47-51.
10. Kim HJ, Kalkhoff RK. Sex steroid influence on triglyceride metabolism. J Clin Invest 1975;56:888-96.
11. Highman TJ, Friedman JE, Huston LP, Wong WW, Catalano PM. Longitudinal changes in maternal serum leptin concentrations, body composition, and resting metabolic rate in pregnancy. Am J Obstet Gynecol 1998;178:1010-5.
12. Lepercq J, Cauzac M, Lahlou N, Timsit J, Girard J, Auwerx, Hauguel-de Mouzon S. Overexpression of placental leptin in diabetic pregnancy: a critical role for insulin. Diabetes 1998;47:847-50.
13. Hauguel-de Mouzon S, Lepercq J, Catalano P. The known and unknown of leptin in pregnancy. Am J Obstet Gynecol 2006;194:1537-45.
14. Considine R, Sinha M, Heiman M. Serum immunoreactive leptin concentrations in normal-weight and obese humans. N Engl J Med 1996;334:292-5.
15. Fruhbeck G, Jebb SA, Prentice AM. Leptin: physiology and pathophysiology. Clin Physiol 1998;18:399-419.
16. Catalano PM, Hoegh M, Minium J, Huston-Presley L, Bernard S, Kalhan S, Hauguel-de Mouzon S. Adiponectin in human pregnancy: implications for regulation of glucose and lipid metabolism. Diabetologia 2006;49:1677-85.
17. Haghiac M, Basu S, Presley L, Serre D, Catalano PM, Hauguel-de Mouzon S. Patterns of adiponectin expression in term pregnancy; impact of obesity. J Clin Endorinol Metab 2014;99:3427-34.
18. Rosario FJ, Schumacher MA, Jiang J, Kanai Y, Powell TL, Jansson T. Chronic maternal infusion of full-length adiponectin in pregnant mice down-regulates placental amino acid transporter activity and expression and decreases fetal growth. J Physiol 2012;590(Pt 6):1495-509.
19. Kallen CB. Steroid hormone synthesis in pregnancy. Obstet Gynecol Clin North Am 2004;31:795-816.
20. Pepe G, Albrecht E. Steroid endocrinology of pregnancy. In: Knobil, E, editor. Glob libr. Womens Med., 2008. ISSN: 1756-2228.
21. Lassance L, Haghiac M, Minium J, Catalano P, Hauguel-de Mouzon S. Obesity-induced down-regulation of the mitochondrial translocator protein (TSPO) impairs placental steroid production. J Clin Endocrinol Metab 2015;100:E11-8.
22. Moog-Lutz C. Tomasetto C, Régnier CH, Wendling C, Lutz Y, Muller D, Chenard MP, Basset P, Rio MC. MLN64 exhibits homology with the steroidogenic acute regulatory protein (STAR) and is over-expressed in human breast carcinomas. Int J Cancer 1997;71:183-191.
23. Fan J, Lindemann P, Feuilloley MG, Papadopoulos V. Structural and functional evolution of the translocator protein (18 kDa). Curr Mol Med 2012;12:369-86.
24. Chernick S, Novak M. Effect of insulin on FFA mobilization and ketosis in fasting pregnant rats. Diabetes 1970;19:563-70.
25. Perley M, Kipnis DM. Effect of glucocorticoids on plasma insulin. N Engl J Med 1966;274:1237-41.
26. Metzger BE, Ravnikar V, Vileisis RA, Freinkel N. Accelerated starvation and the skipped breakfast in late normal pregnancy. Lancet 1982;i:588-92.
27. Catalano PM, Drago NM, Amini SB. Longitudinal changes in pancreatic beta-cell function and metabolic clearance rate of insulin in pregnant women with normal and abnormal glucose tolerance. Diabetes Care 1998;21:403-8.
28. Ryan EA, OSullivan MJ, Skyler JS. Insulin action during pregnancy studies with the euglycemic clamp technique. Diabetes 1985;34:380-9.
29. Berson SA, Yalow RS. Insulin "antagonists" and insulin resistance. In: Ellenberg M, Rifkin H, editors. Diabetes mellitus: theory and practice, New York: McGraw-Hill, 1970:388-423.
30. Spellacy WN, Goetz FC. Plasma insulin in normal late pregnancy. N Engl J Med 1963;268:988-91.
31. Turner RC, Harris E, Ounsted M, Ponsford C. Two abnormalities of glucose-induced insulin secretion: dose-response characteristics and insulin sensitivity. Acta Endocrinol (Copenh) 1979;92:148-65.
32. Buchanan TA, Metzger BE, Freinkel N, Bergman RN. Insulin sensitivity and B-cell responsiveness to glucose during late pregnancy in lean and moderately obese women with normal glucose tolerance or mild gestational diabetes. Am J Obstet Gynecol 1990;162:1008-14.
33. Catalano PM, Hauguel-De Mouzon S. Is it time to revisit the Pedersen hypothesis in the face of the obesity epidemic? Am J Obstet Gynecol 2011;204:479-87.
34. Hauguel-de Mouzon S, Guerre-Millo M. The placenta cytokine network and inflammatory signals. Placenta 2006;27:794-8.
35. Kirwan JP, Hauguel-De Mouzon S, Lepercq J, Challier JC, Huston- Presley L, Friedman JE, Kalhan SC, Catalano PM. TNF-alpha is a predictor of insulin resistance in human pregnancy. Diabetes 2002;51:2207-13.
36. Kim JK. Fat uses a TOLL-road to connect inflammation and diabetes. Cell Metab 2006;4:417-9.
37. Shi H, Kokoeva MV, Inouye K, Tzameli I, Yin H, Flier J. TLR4 links innate immunity and fatty acid-induced insulin resistance. J Clin Invest 2006;116:3015-25.
38. Tsukumo DM, Carvalho-Filho MA, Carvalheira JB, Prada PO, Hirabara SM, Schenka AA, Arajo EP, Vassallo J, Curi R, Velloso LA, Saad JA. Loss-of-function mutation in Toll-like receptor 4 prevents diet-induced obesity and insulin resistance. Diabetes 2007;56:1986-98.
39. Ng M, Fleming T, Robinson M, Thomson B, Graetz N, Margono C, Mullany EC, Biryukov S, Abbafati C, Abera SF, Abraham JP, Abu-Rmeileh NM, Achoki T, AlBuhairan FS, Alemu ZA, Alfonso R, Ali MK, Ali R, Guzman NA, Ammar W, Anwari P, Banerjee A, Barquera S, Basu S, Bennett DA, Bhutta Z, Blore J, Cabral N, Nonato IC, Chang JC, Chowdhury R, Courville KJ, Criqui MH, Cundiff DK, Dabhadkar KC, Dandona L, Davis A, Dayama A, Dharmaratne SD, Ding EL, Durrani AM, Esteghamati A, Farzadfar F, Fay DF, Feigin VL, Flaxman A, Forouzanfar MH, Goto A, Green MA, Gupta R, Hafezi-Nejad N, Hankey GJ, Harewood HC, Havmoeller R, Hay S, Hernandez L, Husseini A, Idrisov BT, Ikeda N, Islami F, Jahangir E, Jassal SK, Jee SH, Jeffreys M, Jonas JB, Kabagambe EK, Khalifa SE, Kengne AP, Khader YS, Khang YH, Kim D, Kimokoti RW, Kinge JM, Kokubo Y, Kosen S, Kwan G, Lai T, Leinsalu M, Li Y, Liang X, Liu S, Logroscino G, Lotufo PA, Lu Y, Ma J, Mainoo NK, Mensah GA, Merriman TR, Mokdad AH, Moschandreas J, Naghavi M, Naheed A, Nand D, Narayan KM, Nelson EL, Neuhouser ML, Nisar MI, Ohkubo T, Oti SO, Pedroza A, Prabhakaran D, Roy N, Sampson U, Seo H, Sepanlou SG, Shibuya K, Shiri R, Shiue I, Singh GM, Singh JA, Skirbekk V, Stapelberg NJ, Sturua L, Sykes BL, Tobias M, Tran BX, Trasande L, Toyoshima H, van de Vijver S, Vasankari TJ, Veerman JL, Velasquez-Melendez G, Vlassov VV, Vollset SE, Vos T, Wang C, Wang X, Weiderpass E, Werdecker A, Wright JL, Yang YC, Yatsuya H, Yoon J, Yoon SJ, Zhao Y, Zhou M, Zhu S, Lopez AD, Murray CJ, Gakidou E. Global, regional, and national prevalence of overweight and obesity in children and adults during 1980-2013: a systematic analysis for the Global Burden of Disease Study 2013. Lancet 2014;384:766-81.
40. Catalano PM. The impact of gestational diabetes and maternal obesity on the mother and her offspring. J Dev Orig Health Dis 2010;1:208-15.
41. Gibson KS, Waters T, Catalano PM. Factors relating to national trends in decreasing birth weight in term singleton deliveries. Society for Gynecologic Investigation 2011;18(Suppl): 210A (abstract F130).
42. Catalano PM, Farrell K, Thomas A, Huston-Presley L, Mencin P, Hauguel-de Mouzon S, Amini SB. Perinatal risk factors for childhood obesity and metabolic dysregulation. Am J Clin Nutr 2009;90:1303-13.
43. Kopp-Hoolihan LE, van Loan MD. Fat mass deposition during pregnancy using a four-component model. J Appl Physiol 1992;87:196-202.
44. Ehrenberg HM, Huston-Presley L, Catalano PM. The influence of obesity and gestational diabetes mellitus on accretion and the distribution of adipose tissue in pregnancy. Am J Obstet Gynecol 2003;189:944-8.
45. Ghio A, Bertolotto A, Resi V, Volpe L, Di Cianni G. Triglyceride metabolism in pregnancy. Adv Clin Chem 2011;55:133-53.
46. Ramsay JE, Ferrell WR, Crawford L, Wallace AM, Greer IA, Sattar N. Maternal obesity is associated with dysregulation of metabolic, vascular, and inflammatory pathways. J Clin Endocrinol Metab 2002;87:4231-7.
47. Ranheim T, Haugen F, Staff AC, Braekke K, Harsem NK, Drevon CA. Adiponectin is reduced in gestational diabetes mellitus in normal weight women. Acta Obstet Gynecol Scand 2004;83:341-7.
48. Mazaki-Tovi S, Romero R, Vaisbuch E, Erez O, Mittal P, Chaiworapongsa T, Kim SK, Gotsch F, Lamont R, Ogge G, Pacora P, Goncalves L, Kim CJ, Gomez R, Espinoza J, Hassan SS, Kusanovic JP. Maternal serum adiponectin multimers in gestational diabetes. J Perinat Med 2009;37:637-50.
49. Lihn AS, Bruun JM, He G, Pedersen SB, Jensen PF, Richelsen B. Lower expression of adiponectin mRNA in visceral adipose tissue in lean and obese subjects. Mol Cell Endocrinol 2004;219:9-15.
50. Misra VK, Trudeau S. The influence of overweight and obesity on longitudinal trends in maternal serum leptin levels during pregnancy. Obesity (Silver Spring) 2011;19:416-21.
51. Ozias MK, Li S, Hull HR, Brooks WM, Carlson SE. Relationship of circulating adipokines to body composition in pregnant women. Adipocyte 2014;4:44-9.
52. Ranganathan S, Maffei M, Kern PA. Adipose tissue OB mRNA expression in humans: discordance with plasma leptin and relationship with adipose TNF-alpha expression. J Lipid Res 1998;39:724-30.
53. Lönnqvist F, Arner P, Nordfors L, Schalling M. Overexpression of the obese(ob) gene in adipose tissue of human obese subjects. Nat Med 1995;1:950-3.
54. Clapham JC, Smith SA, Moore GB, Hughes MG, Azam H, Scott A, Jung RT. Plasma leptin concentrations and OB gene expression in subcutaneous adipose tissue are not regulated acutely by physiological hyperinsulinaemia in lean and obese humans. Int J Obes Relat Metab Disord 1997;21:178-83.
55. Blanchette S, Marceau P, Biron S, Brochu G, Tchernof A. Circulating progesterone and obesity in men. Horm Metab Res 2006;38:330-5.
56. Mele J, Muralimanoharan S, Maloyan A, Myatt L. Impaired mitochondrial function in human placenta with increased maternal adiposity. Am J Physiol Endocrinol Metab 2014;307:E419-25.
57. Petersen KF, Befroy D, Dufour S, Dziura J, Ariyan C, Rothman DL, DiPietro L, Cline GW, Shulman GI. Mitochondrial dysfunction in the elderly: possible role in insulin resistance. Science 2003;300:1140-2.
58. Kelley DE, He J, Menshikova EV, Ritov VB. Dysfunction of mitochondria in human skeletal muscle in type 2. Diabetes 2002;51:2944-50.
59. Bournat JC, Brown CW. Mitochondrial dysfunction in obesity. Curr Opin Endocrinol Diabetes Obes 2010;17:446-52.
60. Catalano PM, Huston L, Amini SB, Kalhan SC. Longitudinal changes in glucose metabolism during pregnancy in obese women with normal glucose tolerance and gestational diabetes mellitus. Am J Obstet Gynecol 1999;180:903-16.
61. Catalano PM, Ehrenberg HM. The short-and long-term implications of maternal and obesity on the mother and her offspring. BJOG 2006;113:1126-33.
62. Matthews DR, Hosker JP, Rudenski AS, Naylor BA, Treacher DF, Turner RC. Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia 1985;28:412-9.
63. Okereke NC, Huston-Presley L, Amini SB, Kalhan S, Catalano PM. Longitudinal changes in energy expenditure and body composition in obese women with normal and impaired glucose tolerance. Am J Physiol Endocrinol Metab 2004;287:E472-9.
64. Sivan E, Homko CJ, Chen X, Reece EA, Boden G. Effect of insulin on fat metabolism during and after normal pregnancy. Diabetes 1999;48:834-8.
65. Eckel RH. Insulin resistance: an adaptation for weight maintenance. Lancet 1992;340:1452-3.
66. Schonfeld P, Wojtczak L. Fatty acids as modulators of the cellular production of reactive oxygen ecies. Free Radic Biol Med 2008;45:231-41.
67. Nakamura MT, Yudell BE, Loor JJ. Regulation of energy metabolism by long-chain fatty acids. Prog Lipid Res 2014;53:124-44.
68. Corkey BE. Banting lecture 2011: hyperinsulinemia: cause or consequence? Diabetes 2012;61:4-13.
69. Boden G, Chen X, Rosner J, Barton M. Effects of a 48-h fat infusion on insulin secretion and glucose utilization. Diabetes 1995;44:1239-42.
70. Xu H, Barnes GT, Yang Q, Tan G, Yang D, Chou CJ, Sole J, Nichols A, Ross JS, Tartaglia LA, Chen H. Chronic inflammation in fat plays a crucial role in the development of obesity-related insulin resistance. J Clin Invest 2003;112:1821-30.
71. Hotamisligil GS, Shargill NS, Spiegelman BM. Adipose expression of tumor necrosis factor-alpha: direct role in obesity-linked insulin resistance. Science 1993;259:87-91.
72. Challier JC, Basu S, Bintein T, Minium J, Hotmire K, Catalano PM, Hauguel-de Mouzon S. Obesity in pregnancy stimulates macrophage accumulation and inflammation in the placenta. Placenta 2008;29:274-81.
73. Basu S, Haghiac M, Surace P, Challier JC, Guerre-Millo M, Singh K, Waters T, Minium J, Presley L, Catalano PM, Hauguel-de Mouzon S. Pre-gravid obesity associates with increased maternal endotoxemia and metabolic inflammation. Obesity (Silver Spring) 2011;19:476-82.
74. Hotamisligil GS. Inflammation and metabolic disorders. Nature 2006;444:860-7.
75. Arner P. Resistin: yet another adipokine tells us that men are not mice. Diabetologia 2005;48:2203-5.